Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children

NCT00461578 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Chlorproguanil-dapsone + artesunate

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]